HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.
äŒæ¥ã³ãŒãBEATW
äŒç€ŸåHeartbeam Inc
äžå Žæ¥Oct 14, 2021
æé«çµå¶è²¬ä»»è
ãCEOãMr. Robert P. (Rob) Eno
åŸæ¥å¡æ°- -
蚌åžçš®é¡Company Warrant
æ±ºç®ææ«- -
æ¬ç€Ÿæåšå°2118 Walsh Ave., Suite 210
éœåžSANTA CLARA
蚌åžååŒæNASDAQ Capital Market Consolidated
åœUnited States of America
éµäŸ¿çªå·95050
é»è©±çªå·14088994443
ãŠã§ããµã€ãhttps://www.heartbeam.com/
äŒæ¥ã³ãŒãBEATW
äžå Žæ¥Oct 14, 2021
æé«çµå¶è²¬ä»»è
ãCEOãMr. Robert P. (Rob) Eno
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã